A Passionate
Commitment

Our Pivotal Phase 3 and Registration-Directed Trials

NOW ENROLLING THE PHASE 2b UNITY-NHL TRIAL:

Ublituximab + Umbralisib Compared to Umbralisib in Patients With Previously Treated Non-Hodgkins Lymphoma (UNITY-NHL) 

__________________________________________________________________________

THE UNITY-CLL PHASE 3 TRIAL (ONGOING, BUT NO LONGER RECRUITING): 

Ublituximab + Umbralisib Compared to Obinutuzumab + Chlorambucil in Patients with Chronic Lymphocytic Leukemia (UNITY-CLL) 

__________________________________________________________________________

THE PHASE 3 ULTIMATE I & II TRIALS (ONGOING, BUT NO LONGER RECRUITING):

Ublituximab as Compared to Teriflunomide in Subjects With Relapsing Multiple Sclerosis (RMS); ULTIMATE I ULTIMATE II

__________________________________________________________________________